Eduardo de Arnaldo Silva Vellutini1, Leonardo Balsalobre2, Diego Rodrigo Hermann3, Aldo Cassol Stamm2. 1. DFV Neurosurgery, São Paulo, Brazil; São Paulo Skull Base Center, São Paulo, Brazil. Electronic address: evellu@terra.com.br. 2. São Paulo Skull Base Center, São Paulo, Brazil; Department of Otolaryngology, Head and Neck Surgery, Federal University of São Paulo, São Paulo, Brazil. 3. São Paulo Skull Base Center, São Paulo, Brazil.
Abstract
OBJECTIVE: To report the use of the endoscopic transnasal transclival approach to treat tumors involving the clivus region. METHODS: The clinical records of 38 patients with clivus lesions were retrospectively reviewed to determine the surgical technique used. All patients were surgically treated using any of the options of the endoscopic transnasal transclival approach at the São Paulo Skull Base Center from 2000-2011. A transsphenoidal, transpterygoidal, retropharyngeal, or a combination of approaches was chosen based on the tumor topography. RESULTS: Chordomas were the most frequent tumor (26 of 38), followed by chondrosarcoma (2 of 38). Biopsy only was performed in 6 patients with metastasis to the clivus, and 1 patient with fibrous dysplasia underwent a planned partial resection. Gross total resection (GTR) was achieved in 15 of 31 (48%) patients with indications for GTR. For centrally located tumors, GTR was achieved in 75% (15 of 20 patients). Fistula was the most frequent complication (6 of 31; 19%) but was much lower in the most recent series using the nasoseptal flap (1 of 16; 6%). Tumors with lateral extensions or with previous treatment had the worst results. The presence of intradural extension was not a limiting factor for GTR. CONCLUSION: Endoscopic transnasal surgery is an alternative approach to treatment of clivus lesions, and, in expert hands, this technique can obtain good results. Lateral extension and previous treatment were factors that could make the surgery more difficult. Intradural extension did not limit the radicality of the removal.
OBJECTIVE: To report the use of the endoscopic transnasal transclival approach to treat tumors involving the clivus region. METHODS: The clinical records of 38 patients with clivus lesions were retrospectively reviewed to determine the surgical technique used. All patients were surgically treated using any of the options of the endoscopic transnasal transclival approach at the São Paulo Skull Base Center from 2000-2011. A transsphenoidal, transpterygoidal, retropharyngeal, or a combination of approaches was chosen based on the tumor topography. RESULTS:Chordomas were the most frequent tumor (26 of 38), followed by chondrosarcoma (2 of 38). Biopsy only was performed in 6 patients with metastasis to the clivus, and 1 patient with fibrous dysplasia underwent a planned partial resection. Gross total resection (GTR) was achieved in 15 of 31 (48%) patients with indications for GTR. For centrally located tumors, GTR was achieved in 75% (15 of 20 patients). Fistula was the most frequent complication (6 of 31; 19%) but was much lower in the most recent series using the nasoseptal flap (1 of 16; 6%). Tumors with lateral extensions or with previous treatment had the worst results. The presence of intradural extension was not a limiting factor for GTR. CONCLUSION: Endoscopic transnasal surgery is an alternative approach to treatment of clivus lesions, and, in expert hands, this technique can obtain good results. Lateral extension and previous treatment were factors that could make the surgery more difficult. Intradural extension did not limit the radicality of the removal.
Authors: Francesco Belotti; Francesco Tengattini; Davide Mattavelli; Marco Ferrari; Antonio Fiorentino; Silvia Agnelli; Alberto Schreiber; Piero Nicolai; Marco Maria Fontanella; Francesco Doglietto Journal: Neurosurg Rev Date: 2020-02-14 Impact factor: 3.042
Authors: Walid I Essayed; Prashin Unadkat; Ahmed Hosny; Sarah Frisken; Marcio S Rassi; Srinivasan Mukundan; James C Weaver; Ossama Al-Mefty; Alexandra J Golby; Ian F Dunn Journal: J Neurosurg Date: 2018-03-02 Impact factor: 5.115
Authors: Alexey N Shkarubo; Konstantin V Koval; Ilia V Chernov; Dmitry N Andreev; Alexey B Kurnosov; Andrey A Panteleyev Journal: Chin Neurosurg J Date: 2018-11-15